Human PAI-1 ELISA Kit ELH-PAII from RayBiotech | Biocompare.com

Supplier Images
Published Figures

Image URL

Be the first to write a review!

Citations:

Figures:

Supplier Page from
RayBiotech for
Human PAI-1 ELISA Kit

Description

RayBio® Human PAI-1 ELISA Kit for cell culture supernatants, plasma, and serum samples. Lead time: Typically ships within 1-2 business days. No Friday shipments

Product Specs
ItemHuman PAI-1 ELISA Kit
CompanyRayBiotech
Price $519.00Supplier Page View Company Product Page
Catalog NumberELH-PAII
ReactivityHuman
Detection TargetSerpin E1 (SERPINE1 / PAI-1)
Quantity1 Plate Kit, 2 Plate Kit, 5 Plate Kit
NCBI Full Gene Nameserpin family E member 1
NCBI Gene AliasesPAI, PAI1, PAI-1, PLANH1
ApplicationsSandwich ELISA
Sample TypeCell Culture Supernatants, Plasma, Serum
Sensitivity35 pg/ml
Detection Range35 pg/ml - 25 ng/ml
Research AreaAngiogenesis, Cardiovascular Disease, Inflammation

Add to Compare List

RayBiotech

RayBiotech

3607 Parkway Lane, Ste. 200

Peachtree Corners, Georgia 30092

United States

Phone: 770-729-2992
888-494-8555

Company Profile

Website: www.RayBiotech.com

(1) Inhibition Effect of Physalis angulata Leaf Extract on Viability, Collagen Type I, and Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) but Not Plasminogen Activator Inhibitor-1 (PAI-1) of Keloid Fibroblast CultureClinical, cosmetic and investigational dermatologyJanuary 1, 2023Widiatmoko A, Fitri LE, Endharti AT, Murlistyarini S, Brahmanti H, Yuniaswan AP, Ekasari DP, Rasyidi F, Nahlia NL, Safitri PR.type I levels were measured using an Elabscience ELISA kit (E-EL-H0184), RayBio Human PAI-1 ELISA Kit (ELH-PAII), and MyBiosource Human Collagen Type I ELISA kit (MBS2506379), respectively. Fibroblast viability was

(2) Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetesDiabetes, obesity & metabolismJanuary 1, 2018Dubé MC, D'Amours M, Weisnagel SJ.

(3) A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasiaCardiovascular drugs and therapyOctober 1, 2014Rahmatzadeh M, Liu HB, Krishna SM, Gaspari TA, Welungoda I, Widdop RE, Dear AE.

Be the First to Write a Review!